These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5544403)

  • 21. Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment.
    Leysen JE; Janssen PF; Niemegeers CJ
    Eur J Pharmacol; 1989 Apr; 163(1):145-9. PubMed ID: 2545460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
    Dyer DC
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Derivatives of 2,5-dimethoxy-4-methylamphetamine (DOM).
    Ho BT; Tansey LW; McIsaac WM
    J Med Chem; 1970 Sep; 13(5):1022. PubMed ID: 5458353
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro stereoselective metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. An apparent enantiomeric interaction.
    McGraw NP; Callery SC; Castagnoli N
    J Med Chem; 1977 Feb; 20(2):185-9. PubMed ID: 836489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
    Jacob P; Shulgin AT
    J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
    Glennon RA; Young R; Jacyno JM
    Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA.
    Young R; Glennon RA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):594-601. PubMed ID: 8632326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).
    Johnson MP; Frescas SP; Oberlender R; Nichols DE
    J Med Chem; 1991 May; 34(5):1662-8. PubMed ID: 1674539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
    Jacob JN; Nichols DE
    J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
    Glennon RA; Young R; Benington F; Morin RD
    J Med Chem; 1982 Oct; 25(10):1163-8. PubMed ID: 7143352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities.
    Glennon RA; Liebowitz SM; Leming-Doot D; Rosecrans JA
    J Med Chem; 1980 Sep; 23(9):990-4. PubMed ID: 7411554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
    Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
    J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
    [No Abstract]   [Full Text] [Related]  

  • 34. Steric effects of substituents on phenethylamine hallucinogens. 3,4-(Methylenedioxy)amphetamine analogues alkylated on the dioxole ring.
    Nichols DE; Kostuba LJ
    J Med Chem; 1979 Oct; 22(10):1264-7. PubMed ID: 513074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
    Ewald AH; Maurer HH
    Toxicol Lett; 2008 Dec; 183(1-3):52-7. PubMed ID: 18938231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).
    Glennon RA; McKenney JD; Young R
    Life Sci; 1984 Oct; 35(14):1475-80. PubMed ID: 6482668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA).
    Nichols DE; Brewster WK; Johnson MP; Oberlender R; Riggs RM
    J Med Chem; 1990 Feb; 33(2):703-10. PubMed ID: 1967651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
    Nichols DE; Frescas S; Marona-Lewicka D; Huang X; Roth BL; Gudelsky GA; Nash JF
    J Med Chem; 1994 Dec; 37(25):4346-51. PubMed ID: 7996545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synthesis of 1,2-diaminopropane derivatives. I. Synthesis of D,L-1-dimethylamino-2-aminopropane].
    Grudziński S; Gronek M; Zalega U
    Acta Pol Pharm; 1976; 33(5):571-6. PubMed ID: 998307
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluorescence polarization immunoassay detection of amphetamine, methamphetamine, and illicit amphetamine analogues.
    Cody JT; Schwarzhoff R
    J Anal Toxicol; 1993; 17(1):23-33. PubMed ID: 8429622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.